Viewing Study NCT06515418


Ignite Creation Date: 2025-12-25 @ 4:46 AM
Ignite Modification Date: 2026-03-04 @ 2:29 AM
Study NCT ID: NCT06515418
Status: TERMINATED
Last Update Posted: 2025-03-13
First Post: 2024-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
Sponsor: BioAge Labs, Inc.
Organization: